跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tapimio 150 mg prolonged-release capsules - UK EMC Drug Approval Details
Approvals
/
UK EMC
/
Tapimio 150 mg prolonged-release capsules
Approved
STANDARD
Tapimio 150 mg prolonged-release capsules
Neuraxpharm UK Ltd
🇬🇧 Electronic Medicines Compendium
Approval Date
N/A
Approval ID
af7865510189f09f
Company
Neuraxpharm UK Ltd
Type
Standard
Approval Details
Approval Id
af7865510189f09f
Drug Approval Emc Name
Tapimio 150 mg prolonged-release capsules
Drug Name
Tapimio 150 mg prolonged-release capsules
Company Name
Neuraxpharm UK Ltd
Company Address
Neuraxpharm UK Ltd, Suite 2, Arlington Flex, Third Floor, Building 1420, Arlington Business Park, Theale, Reading, Berkshire, RG7 4SA, UK
Company Telephone
0118 211 4039
Company Medical Info Email
medinfo-uk@neuraxpharm.com
Atc Code
N02AX06
Legal Category
Prescription only medicine
Active Ingredients
Approved
Quick Info
Agency
UK EMC
Country
🇬🇧
Approval ID
af7865510189f09f
Type
Standard
Back to UK EMC Approvals